H1B Report
Side-by-side comparison

Bristol-Myers Squibb Company vs WIPRO LIMITED

A direct H-1B sponsorship comparison built from the same DOL Labor Condition Application data that drives every page on H1B Report. Total filings, outcome rates, top occupations and yearly demand side-by-side.

Entity A
Bristol-Myers Squibb Company
NJRank #FEIN 22-0790350
Entity B
WIPRO LIMITED
NJRank #6FEIN 98-0154401

Key metrics

All percentages are share of total LCAs filed by each sponsor.

MetricBristol-Myers Squibb CompanyWIPRO LIMITED
Total filings1,89072,392
Certified %93.33%91.61%
Denied %0.37%0.37%
Withdrawn %2.43%1.37%
Cert-withdrawn %3.86%6.64%
Rank#6
Active yearsFY2010–FY2026FY2010–FY2026
Worksite stateNJNJ

Outcomes — Bristol-Myers Squibb Company

DOL case-status mix.

Outcome breakdown: Certified 93.3%, Cert-withdrawn 3.9%, Withdrawn 2.4%, Denied 0.4%
Outcome breakdown
OutcomeShare
Certified93.3%
Cert-withdrawn3.9%
Withdrawn2.4%
Denied0.4%
Certified93.3%
Cert-withdrawn3.9%
Withdrawn2.4%
Denied0.4%

Outcomes — WIPRO LIMITED

DOL case-status mix.

Outcome breakdown: Certified 91.6%, Cert-withdrawn 6.6%, Withdrawn 1.4%, Denied 0.4%
Outcome breakdown
OutcomeShare
Certified91.6%
Cert-withdrawn6.6%
Withdrawn1.4%
Denied0.4%
Certified91.6%
Cert-withdrawn6.6%
Withdrawn1.4%
Denied0.4%

Yearly filing volume

Year-over-year H-1B demand for each sponsor.

Bristol-Myers Squibb Company
Time series: 17 points from FY2010 to FY2026
Time series
PeriodValue
FY201096
FY201179
FY201274
FY201364
FY201485
FY201589
FY201696
FY201788
FY2018106
FY2019111
FY202039
FY2021107
FY202266
FY2023114
FY2024282
FY2025251
FY2026143
WIPRO LIMITED
Time series: 17 points from FY2010 to FY2026
Time series
PeriodValue
FY20103,039
FY20113,025
FY20127,031
FY20136,574
FY20148,104
FY201511,824
FY201610,254
FY20175,012
FY20186,067
FY20194,154
FY202094
FY2021128
FY202297
FY2023554
FY20242,296
FY20252,289
FY20261,850

Top 5 occupations — Bristol-Myers Squibb Company

Top 5 occupations — WIPRO LIMITED

Swap an entity
Replace either sponsor above without losing the comparison. 2-way for now; 3+ comparison coming soon.